CureApp, Inc. announced that it has raised Ã7,000 million in a equity round of funding on August 16, 2022. The transaction will include participation from new investor, The Carlyle Group Inc. The company has raised Ã13,400 million till date. The Carlyle Group Inc. will have one board seat as part of the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.11 USD | +1.07% | +2.01% | +13.32% |
Apr. 26 | Sector Update: Financial Stocks Mixed Late Afternoon | MT |
Apr. 26 | The Carlyle Group Said to be Mulling Sale of Tamko | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.32% | 16.39B | |
-6.44% | 89.1B | |
+15.32% | 83.96B | |
+12.36% | 26.03B | |
-6.65% | 17.21B | |
+6.74% | 13.87B | |
-16.11% | 13.21B | |
+16.00% | 9.45B | |
+26.11% | 8.65B | |
+27.22% | 6.92B |
- Stock Market
- Equities
- CG Stock
- News The Carlyle Group Inc.
- CureApp, Inc. announced that it has received Ñ7 billion in funding from The Carlyle Group Inc.